I get that but Lexaria is currently values at $25 million. That’s all 4 subsidiaries. For argument sake if we say they are each worth 25% that’s $6.25m. If lxrp traded at $1 that would be $90m Or 22.5m. That seems like a big difference but not for a company like Altria.
I don’t think Chris would sell the nicotine division for 22.5m.